Our Reports
Automotive ReportsElectronics & SemiconductorTelecom & ITTechnology & ITConsumer GoodsHealthcareFood & BeveragesChemical
Our Links
About UsContact UsPress ReleaseNewsOur Blogs

Int'l : +1(646) 600-5072 | query@kbvresearch.com

Global Onychomycosis Market Size, Share & Industry Trends Analysis Report By Type (Distal Subungual, Proximal Subungual, White Superficial and Others), By Treatment (Topical, Oral and Others), By Regional Outlook and Forecast, 2022 - 2028

Published Date : 28-Feb-2023

Pages: 164

Formats: PDF

The Global Onychomycosis Market size is expected to reach $4.5 billion by 2028, rising at a market growth of 4.8% CAGR during the forecast period.

A fungal infection of nails called onychomycosis results in thickening and discoloration of the nail plate. In general, the word onychomycosis covers infections caused by yeasts, saprophytic molds, and dermatophytes in addition to dermatophytes. Though fingernails, as well as toenails, can get infected, toenail onychomycosis is more common. Recent studies have shown that mixed infections and infections brought on by non-dermatophyte molds (NDMs) are more common, particularly in warmer climates.

Onychomycosis Market Size - Global Opportunities and Trends Analysis Report 2018-2028

The dermatophyte-induced onychomycosis condition is known as tinea unguium. Subtypes of onychomycosis are categorized according to the invasion pattern. The most prevalent form of onychomycosis, known as distal subungual onychomycosis (DSO), happens when the fungus colonizes the distal portion of the nail plate. Fungi infiltrate the nail plate's outermost layers in superficial white onychomycosis (SWO).

The organism that causes proximal subungual onychomycosis (PSO) first invades from the underside of the proximal nail fold, then the infection subsequently spreads distally. Additionally, Endonyx onychomycosis (EO) refers to the nail plate's fungal invasion that does not involve nail bed infection. Total dystrophic onychomycosis (TDO), which may follow any other subtypes, is the final stage of onychomycosis. Clinically resembling both the non-fungal and fungal nail disorders, secondary onychomycosis (SO) refers to the non-fungal nail condition (that is, psoriasis) along with a secondary fungal infection.

COVID-19 Impact Analysis

As many hospital institutions and primary care clinics switched their attention to COVID-19 patients, the pandemic led to a decline in diagnoses and had an impact on the sales of medications and other onychomycosis treatment options. In addition, COVID-19 also affected the immunity of people, which increased the chances for acquiring fungal diseases like onychomycosis. The risk of recurrence also multiplied for people who already had the infection. Therefore, the pandemic had an adverse impact on the onychomycosis market.

Market Growth Factors

Rising research and development of potential candidates in the pipeline

The rising prevalence of onychomycosis coupled with a lack of viable treatments have increased the demand for better medication. Many of the topical medications on the market cannot reach the depths of the nail bed, making it impossible to entirely heal the infection. As a result, many businesses are trying hard to find compounds that penetrate the nails deeper to overcome this difficulty. Numerous businesses are actively developing new treatments, including BB2603 (Blueberry Therapeutics), Hallux Terbinafine Subungual Gel, and MOB-015 (Moberg Pharma).

Growing prevalence of dermatophytic onychomycosis

Onychomycosis' increasing incidence is one of the major factors propelling the market's expansion. Infection of the toenail onychomycosis is far more common than that of the fingernails. The rising prevalence of dermatophyte-caused nail fungal infections and a large rise in the number of prescriptions are propelling the demand for onychomycosis treatment. A significant number of the world's population has onychomycosis, with millions suffering from nail fungus. A further factor contributing to the rise in dermatophytic infection is the rising incidence of diabetes. Hence, in the coming years, all these factors will expedite the need for onychomycosis treatment, which would benefit the market.

Market Restraining Factor

Low demand elasticity and non-life-threatening condition

The non-life-threatening characteristics of dermatophytic onychomycosis and the treatment's poor efficacy have also led to intense competition from ineffective alternative treatment methods. For instance, tea tree oil is a substitute product that is increasingly utilized to treat nail infections. Since the current medications licensed for the treatment option of onychomycosis have the potential for significant side effects, liver screening and monitoring are necessary. Therefore, the lower demand for the treatment have the potential to hamper the expansion of the market.

Type Outlook

Based on type, the onychomycosis market is categorized into distal subungual, white superficial, proximal subungual, and others. The distal subungual segment garnered the highest revenue share in the onychomycosis market in 2021. The segment's dominance is linked to the FDA's clearance of more generic drugs due to rising demand and rising generic prevalence. Additionally, there are more pharmaceuticals in the pipeline to address the increased demand for effective medications. The most typical kind of onychomycosis is distal subungual. In this, the onycholytic area's proximal edge is ragged, and yellow-white spikes protrude into the nail plate.

Onychomycosis Market Share and Industry Analysis Report 2021

Treatment Outlook

On the basis of treatment, the onychomycosis market is divided into oral, topical, and others. The oral segment recorded a significant revenue share in the onychomycosis market in 2021. The segment is growing since oral medications have greater treatment cure rates as well as shorter treatment periods than other forms of antifungals. For example, terbinafine hydrochloride oral medication is the most used treatment for onychomycosis. Additionally, to combat the rising incidence of onychomycosis, some generic drug makers are introducing oral medicines. Theophylline extended-release (ER) tablets, for example, were approved by the U.S. FDA in June 2021.

Onychomycosis Market Report Coverage
Report Attribute Details
Market size value in 2021 USD 3.3 Billion
Market size forecast in 2028 USD 4.5 Billion
Base Year 2021
Historical Period 2018 to 2020
Forecast Period 2022 to 2028
Revenue Growth Rate CAGR of 4.8% from 2022 to 2028
Number of Pages 164
Number of Table 270
Report coverage Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling
Segments covered Type, Treatment, Region
Country scope US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Australia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers
  • Rising research and development of potential candidates in the pipeline
  • Growing prevalence of dermatophytic onychomycosis
Restraints
  • Low demand elasticity and non-life-threatening condition

Regional Outlook

Based on region, the onychomycosis market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment witnessed the maximum revenue share in the onychomycosis market in 2021. Onychomycosis's increased frequency in the region as well as helpful government policies can be attributed to the growth. Among the developed nations, North America has one of the highest per capita healthcare costs. Additionally, many people in North America have onychomycosis. The rising incidence rate is increasing the need for effective onychomycosis treatments in the fight against the disease. Due to this, American businesses have made large expenditures in the creation of these medications.

Free Valuable Insights: Global Onychomycosis Market size to reach USD 4.5 Billion by 2028

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Pfizer, Inc., Teva Pharmaceuticals Industries Ltd., Abbott Laboratories, Bausch Health Companies, Inc., Bayer AG, Cipla Limited, Merck & Co., Inc., Novartis AG, Sun Pharmaceutical Industries Ltd., and GlaxoSmithKline PLC.

Scope of the Study

Market Segments Covered in the Report:

By Type

  • Distal Subungual
  • Proximal Subungual
  • White Superficial
  • Others

By Treatment

  • Topical
  • Oral
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Australia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Pfizer, Inc.
  • Teva Pharmaceuticals Industries Ltd.
  • Abbott Laboratories
  • Bausch Health Companies, Inc.
  • Bayer AG
  • Cipla Limited
  • Merck & Co., Inc.
  • Novartis AG
  • Sun Pharmaceutical Industries Ltd.
  • GlaxoSmithKline PLC
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Onychomycosis Market, by Type
1.4.2 Global Onychomycosis Market, by Treatment
1.4.3 Global Onychomycosis Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Global Onychomycosis Market by Type
3.1 Global Distal Subungual Market by Region
3.2 Global Proximal Subungual Market by Region
3.3 Global White Superficial Market by Region
3.4 Global Others Market by Region

Chapter 4. Global Onychomycosis Market by Treatment
4.1 Global Topical Market by Region
4.2 Global Oral Market by Region
4.3 Global Others Market by Region

Chapter 5. Global Onychomycosis Market by Region
5.1 North America Onychomycosis Market
5.1.1 North America Onychomycosis Market by Type
5.1.1.1 North America Distal Subungual Market by Country
5.1.1.2 North America Proximal Subungual Market by Country
5.1.1.3 North America White Superficial Market by Country
5.1.1.4 North America Others Market by Country
5.1.2 North America Onychomycosis Market by Treatment
5.1.2.1 North America Topical Market by Country
5.1.2.2 North America Oral Market by Country
5.1.2.3 North America Others Market by Country
5.1.3 North America Onychomycosis Market by Country
5.1.3.1 US Onychomycosis Market
5.1.3.1.1 US Onychomycosis Market by Type
5.1.3.1.2 US Onychomycosis Market by Treatment
5.1.3.2 Canada Onychomycosis Market
5.1.3.2.1 Canada Onychomycosis Market by Type
5.1.3.2.2 Canada Onychomycosis Market by Treatment
5.1.3.3 Mexico Onychomycosis Market
5.1.3.3.1 Mexico Onychomycosis Market by Type
5.1.3.3.2 Mexico Onychomycosis Market by Treatment
5.1.3.4 Rest of North America Onychomycosis Market
5.1.3.4.1 Rest of North America Onychomycosis Market by Type
5.1.3.4.2 Rest of North America Onychomycosis Market by Treatment
5.2 Europe Onychomycosis Market
5.2.1 Europe Onychomycosis Market by Type
5.2.1.1 Europe Distal Subungual Market by Country
5.2.1.2 Europe Proximal Subungual Market by Country
5.2.1.3 Europe White Superficial Market by Country
5.2.1.4 Europe Others Market by Country
5.2.2 Europe Onychomycosis Market by Treatment
5.2.2.1 Europe Topical Market by Country
5.2.2.2 Europe Oral Market by Country
5.2.2.3 Europe Others Market by Country
5.2.3 Europe Onychomycosis Market by Country
5.2.3.1 Germany Onychomycosis Market
5.2.3.1.1 Germany Onychomycosis Market by Type
5.2.3.1.2 Germany Onychomycosis Market by Treatment
5.2.3.2 UK Onychomycosis Market
5.2.3.2.1 UK Onychomycosis Market by Type
5.2.3.2.2 UK Onychomycosis Market by Treatment
5.2.3.3 France Onychomycosis Market
5.2.3.3.1 France Onychomycosis Market by Type
5.2.3.3.2 France Onychomycosis Market by Treatment
5.2.3.4 Russia Onychomycosis Market
5.2.3.4.1 Russia Onychomycosis Market by Type
5.2.3.4.2 Russia Onychomycosis Market by Treatment
5.2.3.5 Spain Onychomycosis Market
5.2.3.5.1 Spain Onychomycosis Market by Type
5.2.3.5.2 Spain Onychomycosis Market by Treatment
5.2.3.6 Italy Onychomycosis Market
5.2.3.6.1 Italy Onychomycosis Market by Type
5.2.3.6.2 Italy Onychomycosis Market by Treatment
5.2.3.7 Rest of Europe Onychomycosis Market
5.2.3.7.1 Rest of Europe Onychomycosis Market by Type
5.2.3.7.2 Rest of Europe Onychomycosis Market by Treatment
5.3 Asia Pacific Onychomycosis Market
5.3.1 Asia Pacific Onychomycosis Market by Type
5.3.1.1 Asia Pacific Distal Subungual Market by Country
5.3.1.2 Asia Pacific Proximal Subungual Market by Country
5.3.1.3 Asia Pacific White Superficial Market by Country
5.3.1.4 Asia Pacific Others Market by Country
5.3.2 Asia Pacific Onychomycosis Market by Treatment
5.3.2.1 Asia Pacific Topical Market by Country
5.3.2.2 Asia Pacific Oral Market by Country
5.3.2.3 Asia Pacific Others Market by Country
5.3.3 Asia Pacific Onychomycosis Market by Country
5.3.3.1 China Onychomycosis Market
5.3.3.1.1 China Onychomycosis Market by Type
5.3.3.1.2 China Onychomycosis Market by Treatment
5.3.3.2 Japan Onychomycosis Market
5.3.3.2.1 Japan Onychomycosis Market by Type
5.3.3.2.2 Japan Onychomycosis Market by Treatment
5.3.3.3 India Onychomycosis Market
5.3.3.3.1 India Onychomycosis Market by Type
5.3.3.3.2 India Onychomycosis Market by Treatment
5.3.3.4 Australia Onychomycosis Market
5.3.3.4.1 Australia Onychomycosis Market by Type
5.3.3.4.2 Australia Onychomycosis Market by Treatment
5.3.3.5 South Korea Onychomycosis Market
5.3.3.5.1 South Korea Onychomycosis Market by Type
5.3.3.5.2 South Korea Onychomycosis Market by Treatment
5.3.3.6 Singapore Onychomycosis Market
5.3.3.6.1 Singapore Onychomycosis Market by Type
5.3.3.6.2 Singapore Onychomycosis Market by Treatment
5.3.3.7 Rest of Asia Pacific Onychomycosis Market
5.3.3.7.1 Rest of Asia Pacific Onychomycosis Market by Type
5.3.3.7.2 Rest of Asia Pacific Onychomycosis Market by Treatment
5.4 LAMEA Onychomycosis Market
5.4.1 LAMEA Onychomycosis Market by Type
5.4.1.1 LAMEA Distal Subungual Market by Country
5.4.1.2 LAMEA Proximal Subungual Market by Country
5.4.1.3 LAMEA White Superficial Market by Country
5.4.1.4 LAMEA Others Market by Country
5.4.2 LAMEA Onychomycosis Market by Treatment
5.4.2.1 LAMEA Topical Market by Country
5.4.2.2 LAMEA Oral Market by Country
5.4.2.3 LAMEA Others Market by Country
5.4.3 LAMEA Onychomycosis Market by Country
5.4.3.1 Brazil Onychomycosis Market
5.4.3.1.1 Brazil Onychomycosis Market by Type
5.4.3.1.2 Brazil Onychomycosis Market by Treatment
5.4.3.2 Argentina Onychomycosis Market
5.4.3.2.1 Argentina Onychomycosis Market by Type
5.4.3.2.2 Argentina Onychomycosis Market by Treatment
5.4.3.3 UAE Onychomycosis Market
5.4.3.3.1 UAE Onychomycosis Market by Type
5.4.3.3.2 UAE Onychomycosis Market by Treatment
5.4.3.4 Saudi Arabia Onychomycosis Market
5.4.3.4.1 Saudi Arabia Onychomycosis Market by Type
5.4.3.4.2 Saudi Arabia Onychomycosis Market by Treatment
5.4.3.5 South Africa Onychomycosis Market
5.4.3.5.1 South Africa Onychomycosis Market by Type
5.4.3.5.2 South Africa Onychomycosis Market by Treatment
5.4.3.6 Nigeria Onychomycosis Market
5.4.3.6.1 Nigeria Onychomycosis Market by Type
5.4.3.6.2 Nigeria Onychomycosis Market by Treatment
5.4.3.7 Rest of LAMEA Onychomycosis Market
5.4.3.7.1 Rest of LAMEA Onychomycosis Market by Type
5.4.3.7.2 Rest of LAMEA Onychomycosis Market by Treatment

Chapter 6. Company Profiles
6.1 Abbott Laboratories
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 SWOT Analysis
6.2 Bausch Health Companies, Inc.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent strategies and developments:
6.2.5.1 Trials and Approvals:
6.3 Bayer AG
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Product Launches and Expansions:
6.4 Cipla Limited
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Regional Analysis
6.4.4 Research & Development Expense
6.4.5 Recent strategies and developments:
6.4.5.1 Product Launches and Product Expansions:
6.5 Sun Pharmaceutical Industries Ltd.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional & Segmental Analysis
6.5.4 Research & Development Expenses
6.5.5 Recent strategies and developments:
6.5.5.1 Acquisition and Mergers:
6.6 GlaxoSmithKline PLC (GSK)
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.6.5 Recent strategies and developments:
6.6.5.1 Partnerships, Collaborations, and Agreements:
6.7 Pfizer, Inc.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional & Segmental Analysis
6.7.4 Research & Development Expense
6.8 Teva Pharmaceutical Industries Ltd.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Regional Analysis
6.8.4 Research & Development Expenses
6.9 Merck & Co., Inc.
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Research & Development Expenses
6.10. Novartis AG
6.10.1 Company Overview
6.10.2 Financial Analysis
6.10.3 Segmental and Regional Analysis
6.10.4 Research & Development Expense
TABLE 1 Global Onychomycosis Market, 2018 - 2021, USD Million
TABLE 2 Global Onychomycosis Market, 2022 - 2028, USD Million
TABLE 3 Global Onychomycosis Market by Type, 2018 - 2021, USD Million
TABLE 4 Global Onychomycosis Market by Type, 2022 - 2028, USD Million
TABLE 5 Global Distal Subungual Market by Region, 2018 - 2021, USD Million
TABLE 6 Global Distal Subungual Market by Region, 2022 - 2028, USD Million
TABLE 7 Global Proximal Subungual Market by Region, 2018 - 2021, USD Million
TABLE 8 Global Proximal Subungual Market by Region, 2022 - 2028, USD Million
TABLE 9 Global White Superficial Market by Region, 2018 - 2021, USD Million
TABLE 10 Global White Superficial Market by Region, 2022 - 2028, USD Million
TABLE 11 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 12 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 13 Global Onychomycosis Market by Treatment, 2018 - 2021, USD Million
TABLE 14 Global Onychomycosis Market by Treatment, 2022 - 2028, USD Million
TABLE 15 Global Topical Market by Region, 2018 - 2021, USD Million
TABLE 16 Global Topical Market by Region, 2022 - 2028, USD Million
TABLE 17 Global Oral Market by Region, 2018 - 2021, USD Million
TABLE 18 Global Oral Market by Region, 2022 - 2028, USD Million
TABLE 19 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 20 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 21 Global Onychomycosis Market by Region, 2018 - 2021, USD Million
TABLE 22 Global Onychomycosis Market by Region, 2022 - 2028, USD Million
TABLE 23 North America Onychomycosis Market, 2018 - 2021, USD Million
TABLE 24 North America Onychomycosis Market, 2022 - 2028, USD Million
TABLE 25 North America Onychomycosis Market by Type, 2018 - 2021, USD Million
TABLE 26 North America Onychomycosis Market by Type, 2022 - 2028, USD Million
TABLE 27 North America Distal Subungual Market by Country, 2018 - 2021, USD Million
TABLE 28 North America Distal Subungual Market by Country, 2022 - 2028, USD Million
TABLE 29 North America Proximal Subungual Market by Country, 2018 - 2021, USD Million
TABLE 30 North America Proximal Subungual Market by Country, 2022 - 2028, USD Million
TABLE 31 North America White Superficial Market by Country, 2018 - 2021, USD Million
TABLE 32 North America White Superficial Market by Country, 2022 - 2028, USD Million
TABLE 33 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 34 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 35 North America Onychomycosis Market by Treatment, 2018 - 2021, USD Million
TABLE 36 North America Onychomycosis Market by Treatment, 2022 - 2028, USD Million
TABLE 37 North America Topical Market by Country, 2018 - 2021, USD Million
TABLE 38 North America Topical Market by Country, 2022 - 2028, USD Million
TABLE 39 North America Oral Market by Country, 2018 - 2021, USD Million
TABLE 40 North America Oral Market by Country, 2022 - 2028, USD Million
TABLE 41 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 42 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 43 North America Onychomycosis Market by Country, 2018 - 2021, USD Million
TABLE 44 North America Onychomycosis Market by Country, 2022 - 2028, USD Million
TABLE 45 US Onychomycosis Market, 2018 - 2021, USD Million
TABLE 46 US Onychomycosis Market, 2022 - 2028, USD Million
TABLE 47 US Onychomycosis Market by Type, 2018 - 2021, USD Million
TABLE 48 US Onychomycosis Market by Type, 2022 - 2028, USD Million
TABLE 49 US Onychomycosis Market by Treatment, 2018 - 2021, USD Million
TABLE 50 US Onychomycosis Market by Treatment, 2022 - 2028, USD Million
TABLE 51 Canada Onychomycosis Market, 2018 - 2021, USD Million
TABLE 52 Canada Onychomycosis Market, 2022 - 2028, USD Million
TABLE 53 Canada Onychomycosis Market by Type, 2018 - 2021, USD Million
TABLE 54 Canada Onychomycosis Market by Type, 2022 - 2028, USD Million
TABLE 55 Canada Onychomycosis Market by Treatment, 2018 - 2021, USD Million
TABLE 56 Canada Onychomycosis Market by Treatment, 2022 - 2028, USD Million
TABLE 57 Mexico Onychomycosis Market, 2018 - 2021, USD Million
TABLE 58 Mexico Onychomycosis Market, 2022 - 2028, USD Million
TABLE 59 Mexico Onychomycosis Market by Type, 2018 - 2021, USD Million
TABLE 60 Mexico Onychomycosis Market by Type, 2022 - 2028, USD Million
TABLE 61 Mexico Onychomycosis Market by Treatment, 2018 - 2021, USD Million
TABLE 62 Mexico Onychomycosis Market by Treatment, 2022 - 2028, USD Million
TABLE 63 Rest of North America Onychomycosis Market, 2018 - 2021, USD Million
TABLE 64 Rest of North America Onychomycosis Market, 2022 - 2028, USD Million
TABLE 65 Rest of North America Onychomycosis Market by Type, 2018 - 2021, USD Million
TABLE 66 Rest of North America Onychomycosis Market by Type, 2022 - 2028, USD Million
TABLE 67 Rest of North America Onychomycosis Market by Treatment, 2018 - 2021, USD Million
TABLE 68 Rest of North America Onychomycosis Market by Treatment, 2022 - 2028, USD Million
TABLE 69 Europe Onychomycosis Market, 2018 - 2021, USD Million
TABLE 70 Europe Onychomycosis Market, 2022 - 2028, USD Million
TABLE 71 Europe Onychomycosis Market by Type, 2018 - 2021, USD Million
TABLE 72 Europe Onychomycosis Market by Type, 2022 - 2028, USD Million
TABLE 73 Europe Distal Subungual Market by Country, 2018 - 2021, USD Million
TABLE 74 Europe Distal Subungual Market by Country, 2022 - 2028, USD Million
TABLE 75 Europe Proximal Subungual Market by Country, 2018 - 2021, USD Million
TABLE 76 Europe Proximal Subungual Market by Country, 2022 - 2028, USD Million
TABLE 77 Europe White Superficial Market by Country, 2018 - 2021, USD Million
TABLE 78 Europe White Superficial Market by Country, 2022 - 2028, USD Million
TABLE 79 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 80 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 81 Europe Onychomycosis Market by Treatment, 2018 - 2021, USD Million
TABLE 82 Europe Onychomycosis Market by Treatment, 2022 - 2028, USD Million
TABLE 83 Europe Topical Market by Country, 2018 - 2021, USD Million
TABLE 84 Europe Topical Market by Country, 2022 - 2028, USD Million
TABLE 85 Europe Oral Market by Country, 2018 - 2021, USD Million
TABLE 86 Europe Oral Market by Country, 2022 - 2028, USD Million
TABLE 87 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 88 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 89 Europe Onychomycosis Market by Country, 2018 - 2021, USD Million
TABLE 90 Europe Onychomycosis Market by Country, 2022 - 2028, USD Million
TABLE 91 Germany Onychomycosis Market, 2018 - 2021, USD Million
TABLE 92 Germany Onychomycosis Market, 2022 - 2028, USD Million
TABLE 93 Germany Onychomycosis Market by Type, 2018 - 2021, USD Million
TABLE 94 Germany Onychomycosis Market by Type, 2022 - 2028, USD Million
TABLE 95 Germany Onychomycosis Market by Treatment, 2018 - 2021, USD Million
TABLE 96 Germany Onychomycosis Market by Treatment, 2022 - 2028, USD Million
TABLE 97 UK Onychomycosis Market, 2018 - 2021, USD Million
TABLE 98 UK Onychomycosis Market, 2022 - 2028, USD Million
TABLE 99 UK Onychomycosis Market by Type, 2018 - 2021, USD Million
TABLE 100 UK Onychomycosis Market by Type, 2022 - 2028, USD Million
TABLE 101 UK Onychomycosis Market by Treatment, 2018 - 2021, USD Million
TABLE 102 UK Onychomycosis Market by Treatment, 2022 - 2028, USD Million
TABLE 103 France Onychomycosis Market, 2018 - 2021, USD Million
TABLE 104 France Onychomycosis Market, 2022 - 2028, USD Million
TABLE 105 France Onychomycosis Market by Type, 2018 - 2021, USD Million
TABLE 106 France Onychomycosis Market by Type, 2022 - 2028, USD Million
TABLE 107 France Onychomycosis Market by Treatment, 2018 - 2021, USD Million
TABLE 108 France Onychomycosis Market by Treatment, 2022 - 2028, USD Million
TABLE 109 Russia Onychomycosis Market, 2018 - 2021, USD Million
TABLE 110 Russia Onychomycosis Market, 2022 - 2028, USD Million
TABLE 111 Russia Onychomycosis Market by Type, 2018 - 2021, USD Million
TABLE 112 Russia Onychomycosis Market by Type, 2022 - 2028, USD Million
TABLE 113 Russia Onychomycosis Market by Treatment, 2018 - 2021, USD Million
TABLE 114 Russia Onychomycosis Market by Treatment, 2022 - 2028, USD Million
TABLE 115 Spain Onychomycosis Market, 2018 - 2021, USD Million
TABLE 116 Spain Onychomycosis Market, 2022 - 2028, USD Million
TABLE 117 Spain Onychomycosis Market by Type, 2018 - 2021, USD Million
TABLE 118 Spain Onychomycosis Market by Type, 2022 - 2028, USD Million
TABLE 119 Spain Onychomycosis Market by Treatment, 2018 - 2021, USD Million
TABLE 120 Spain Onychomycosis Market by Treatment, 2022 - 2028, USD Million
TABLE 121 Italy Onychomycosis Market, 2018 - 2021, USD Million
TABLE 122 Italy Onychomycosis Market, 2022 - 2028, USD Million
TABLE 123 Italy Onychomycosis Market by Type, 2018 - 2021, USD Million
TABLE 124 Italy Onychomycosis Market by Type, 2022 - 2028, USD Million
TABLE 125 Italy Onychomycosis Market by Treatment, 2018 - 2021, USD Million
TABLE 126 Italy Onychomycosis Market by Treatment, 2022 - 2028, USD Million
TABLE 127 Rest of Europe Onychomycosis Market, 2018 - 2021, USD Million
TABLE 128 Rest of Europe Onychomycosis Market, 2022 - 2028, USD Million
TABLE 129 Rest of Europe Onychomycosis Market by Type, 2018 - 2021, USD Million
TABLE 130 Rest of Europe Onychomycosis Market by Type, 2022 - 2028, USD Million
TABLE 131 Rest of Europe Onychomycosis Market by Treatment, 2018 - 2021, USD Million
TABLE 132 Rest of Europe Onychomycosis Market by Treatment, 2022 - 2028, USD Million
TABLE 133 Asia Pacific Onychomycosis Market, 2018 - 2021, USD Million
TABLE 134 Asia Pacific Onychomycosis Market, 2022 - 2028, USD Million
TABLE 135 Asia Pacific Onychomycosis Market by Type, 2018 - 2021, USD Million
TABLE 136 Asia Pacific Onychomycosis Market by Type, 2022 - 2028, USD Million
TABLE 137 Asia Pacific Distal Subungual Market by Country, 2018 - 2021, USD Million
TABLE 138 Asia Pacific Distal Subungual Market by Country, 2022 - 2028, USD Million
TABLE 139 Asia Pacific Proximal Subungual Market by Country, 2018 - 2021, USD Million
TABLE 140 Asia Pacific Proximal Subungual Market by Country, 2022 - 2028, USD Million
TABLE 141 Asia Pacific White Superficial Market by Country, 2018 - 2021, USD Million
TABLE 142 Asia Pacific White Superficial Market by Country, 2022 - 2028, USD Million
TABLE 143 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 144 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 145 Asia Pacific Onychomycosis Market by Treatment, 2018 - 2021, USD Million
TABLE 146 Asia Pacific Onychomycosis Market by Treatment, 2022 - 2028, USD Million
TABLE 147 Asia Pacific Topical Market by Country, 2018 - 2021, USD Million
TABLE 148 Asia Pacific Topical Market by Country, 2022 - 2028, USD Million
TABLE 149 Asia Pacific Oral Market by Country, 2018 - 2021, USD Million
TABLE 150 Asia Pacific Oral Market by Country, 2022 - 2028, USD Million
TABLE 151 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 152 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 153 Asia Pacific Onychomycosis Market by Country, 2018 - 2021, USD Million
TABLE 154 Asia Pacific Onychomycosis Market by Country, 2022 - 2028, USD Million
TABLE 155 China Onychomycosis Market, 2018 - 2021, USD Million
TABLE 156 China Onychomycosis Market, 2022 - 2028, USD Million
TABLE 157 China Onychomycosis Market by Type, 2018 - 2021, USD Million
TABLE 158 China Onychomycosis Market by Type, 2022 - 2028, USD Million
TABLE 159 China Onychomycosis Market by Treatment, 2018 - 2021, USD Million
TABLE 160 China Onychomycosis Market by Treatment, 2022 - 2028, USD Million
TABLE 161 Japan Onychomycosis Market, 2018 - 2021, USD Million
TABLE 162 Japan Onychomycosis Market, 2022 - 2028, USD Million
TABLE 163 Japan Onychomycosis Market by Type, 2018 - 2021, USD Million
TABLE 164 Japan Onychomycosis Market by Type, 2022 - 2028, USD Million
TABLE 165 Japan Onychomycosis Market by Treatment, 2018 - 2021, USD Million
TABLE 166 Japan Onychomycosis Market by Treatment, 2022 - 2028, USD Million
TABLE 167 India Onychomycosis Market, 2018 - 2021, USD Million
TABLE 168 India Onychomycosis Market, 2022 - 2028, USD Million
TABLE 169 India Onychomycosis Market by Type, 2018 - 2021, USD Million
TABLE 170 India Onychomycosis Market by Type, 2022 - 2028, USD Million
TABLE 171 India Onychomycosis Market by Treatment, 2018 - 2021, USD Million
TABLE 172 India Onychomycosis Market by Treatment, 2022 - 2028, USD Million
TABLE 173 Australia Onychomycosis Market, 2018 - 2021, USD Million
TABLE 174 Australia Onychomycosis Market, 2022 - 2028, USD Million
TABLE 175 Australia Onychomycosis Market by Type, 2018 - 2021, USD Million
TABLE 176 Australia Onychomycosis Market by Type, 2022 - 2028, USD Million
TABLE 177 Australia Onychomycosis Market by Treatment, 2018 - 2021, USD Million
TABLE 178 Australia Onychomycosis Market by Treatment, 2022 - 2028, USD Million
TABLE 179 South Korea Onychomycosis Market, 2018 - 2021, USD Million
TABLE 180 South Korea Onychomycosis Market, 2022 - 2028, USD Million
TABLE 181 South Korea Onychomycosis Market by Type, 2018 - 2021, USD Million
TABLE 182 South Korea Onychomycosis Market by Type, 2022 - 2028, USD Million
TABLE 183 South Korea Onychomycosis Market by Treatment, 2018 - 2021, USD Million
TABLE 184 South Korea Onychomycosis Market by Treatment, 2022 - 2028, USD Million
TABLE 185 Singapore Onychomycosis Market, 2018 - 2021, USD Million
TABLE 186 Singapore Onychomycosis Market, 2022 - 2028, USD Million
TABLE 187 Singapore Onychomycosis Market by Type, 2018 - 2021, USD Million
TABLE 188 Singapore Onychomycosis Market by Type, 2022 - 2028, USD Million
TABLE 189 Singapore Onychomycosis Market by Treatment, 2018 - 2021, USD Million
TABLE 190 Singapore Onychomycosis Market by Treatment, 2022 - 2028, USD Million
TABLE 191 Rest of Asia Pacific Onychomycosis Market, 2018 - 2021, USD Million
TABLE 192 Rest of Asia Pacific Onychomycosis Market, 2022 - 2028, USD Million
TABLE 193 Rest of Asia Pacific Onychomycosis Market by Type, 2018 - 2021, USD Million
TABLE 194 Rest of Asia Pacific Onychomycosis Market by Type, 2022 - 2028, USD Million
TABLE 195 Rest of Asia Pacific Onychomycosis Market by Treatment, 2018 - 2021, USD Million
TABLE 196 Rest of Asia Pacific Onychomycosis Market by Treatment, 2022 - 2028, USD Million
TABLE 197 LAMEA Onychomycosis Market, 2018 - 2021, USD Million
TABLE 198 LAMEA Onychomycosis Market, 2022 - 2028, USD Million
TABLE 199 LAMEA Onychomycosis Market by Type, 2018 - 2021, USD Million
TABLE 200 LAMEA Onychomycosis Market by Type, 2022 - 2028, USD Million
TABLE 201 LAMEA Distal Subungual Market by Country, 2018 - 2021, USD Million
TABLE 202 LAMEA Distal Subungual Market by Country, 2022 - 2028, USD Million
TABLE 203 LAMEA Proximal Subungual Market by Country, 2018 - 2021, USD Million
TABLE 204 LAMEA Proximal Subungual Market by Country, 2022 - 2028, USD Million
TABLE 205 LAMEA White Superficial Market by Country, 2018 - 2021, USD Million
TABLE 206 LAMEA White Superficial Market by Country, 2022 - 2028, USD Million
TABLE 207 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 208 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 209 LAMEA Onychomycosis Market by Treatment, 2018 - 2021, USD Million
TABLE 210 LAMEA Onychomycosis Market by Treatment, 2022 - 2028, USD Million
TABLE 211 LAMEA Topical Market by Country, 2018 - 2021, USD Million
TABLE 212 LAMEA Topical Market by Country, 2022 - 2028, USD Million
TABLE 213 LAMEA Oral Market by Country, 2018 - 2021, USD Million
TABLE 214 LAMEA Oral Market by Country, 2022 - 2028, USD Million
TABLE 215 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 216 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 217 LAMEA Onychomycosis Market by Country, 2018 - 2021, USD Million
TABLE 218 LAMEA Onychomycosis Market by Country, 2022 - 2028, USD Million
TABLE 219 Brazil Onychomycosis Market, 2018 - 2021, USD Million
TABLE 220 Brazil Onychomycosis Market, 2022 - 2028, USD Million
TABLE 221 Brazil Onychomycosis Market by Type, 2018 - 2021, USD Million
TABLE 222 Brazil Onychomycosis Market by Type, 2022 - 2028, USD Million
TABLE 223 Brazil Onychomycosis Market by Treatment, 2018 - 2021, USD Million
TABLE 224 Brazil Onychomycosis Market by Treatment, 2022 - 2028, USD Million
TABLE 225 Argentina Onychomycosis Market, 2018 - 2021, USD Million
TABLE 226 Argentina Onychomycosis Market, 2022 - 2028, USD Million
TABLE 227 Argentina Onychomycosis Market by Type, 2018 - 2021, USD Million
TABLE 228 Argentina Onychomycosis Market by Type, 2022 - 2028, USD Million
TABLE 229 Argentina Onychomycosis Market by Treatment, 2018 - 2021, USD Million
TABLE 230 Argentina Onychomycosis Market by Treatment, 2022 - 2028, USD Million
TABLE 231 UAE Onychomycosis Market, 2018 - 2021, USD Million
TABLE 232 UAE Onychomycosis Market, 2022 - 2028, USD Million
TABLE 233 UAE Onychomycosis Market by Type, 2018 - 2021, USD Million
TABLE 234 UAE Onychomycosis Market by Type, 2022 - 2028, USD Million
TABLE 235 UAE Onychomycosis Market by Treatment, 2018 - 2021, USD Million
TABLE 236 UAE Onychomycosis Market by Treatment, 2022 - 2028, USD Million
TABLE 237 Saudi Arabia Onychomycosis Market, 2018 - 2021, USD Million
TABLE 238 Saudi Arabia Onychomycosis Market, 2022 - 2028, USD Million
TABLE 239 Saudi Arabia Onychomycosis Market by Type, 2018 - 2021, USD Million
TABLE 240 Saudi Arabia Onychomycosis Market by Type, 2022 - 2028, USD Million
TABLE 241 Saudi Arabia Onychomycosis Market by Treatment, 2018 - 2021, USD Million
TABLE 242 Saudi Arabia Onychomycosis Market by Treatment, 2022 - 2028, USD Million
TABLE 243 South Africa Onychomycosis Market, 2018 - 2021, USD Million
TABLE 244 South Africa Onychomycosis Market, 2022 - 2028, USD Million
TABLE 245 South Africa Onychomycosis Market by Type, 2018 - 2021, USD Million
TABLE 246 South Africa Onychomycosis Market by Type, 2022 - 2028, USD Million
TABLE 247 South Africa Onychomycosis Market by Treatment, 2018 - 2021, USD Million
TABLE 248 South Africa Onychomycosis Market by Treatment, 2022 - 2028, USD Million
TABLE 249 Nigeria Onychomycosis Market, 2018 - 2021, USD Million
TABLE 250 Nigeria Onychomycosis Market, 2022 - 2028, USD Million
TABLE 251 Nigeria Onychomycosis Market by Type, 2018 - 2021, USD Million
TABLE 252 Nigeria Onychomycosis Market by Type, 2022 - 2028, USD Million
TABLE 253 Nigeria Onychomycosis Market by Treatment, 2018 - 2021, USD Million
TABLE 254 Nigeria Onychomycosis Market by Treatment, 2022 - 2028, USD Million
TABLE 255 Rest of LAMEA Onychomycosis Market, 2018 - 2021, USD Million
TABLE 256 Rest of LAMEA Onychomycosis Market, 2022 - 2028, USD Million
TABLE 257 Rest of LAMEA Onychomycosis Market by Type, 2018 - 2021, USD Million
TABLE 258 Rest of LAMEA Onychomycosis Market by Type, 2022 - 2028, USD Million
TABLE 259 Rest of LAMEA Onychomycosis Market by Treatment, 2018 - 2021, USD Million
TABLE 260 Rest of LAMEA Onychomycosis Market by Treatment, 2022 - 2028, USD Million
TABLE 261 Key Information – Abbott Laboratories
TABLE 262 key information – Bausch Health Companies, Inc.
TABLE 263 Key Information – Bayer AG
TABLE 264 Key Information – Cipla Limited
TABLE 265 Key Information – Sun Pharmaceutical Industries Ltd.
TABLE 266 Key Information – GlaxoSmithKline PLC (GSK)
TABLE 267 Key Information – Pfizer, Inc.
TABLE 268 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 269 KEY INFORMATION - Merck & Co., Inc.
TABLE 270 Key Information – Novartis AG

List of Figures
FIG 1 Methodology for the research
FIG 2 Global Onychomycosis Market Share by Type, 2021
FIG 3 Global Onychomycosis Market Share by Type, 2028
FIG 4 Global Onychomycosis Market by Type, 2018 - 2028, USD Million
FIG 5 Global Onychomycosis Market Share by Treatment, 2021
FIG 6 Global Onychomycosis Market Share by Treatment, 2028
FIG 7 Global Onychomycosis Market by Treatment, 2018 - 2028, USD Million
FIG 8 Global Onychomycosis Market Share by Region, 2021
FIG 9 Global Onychomycosis Market Share by Region, 2028
FIG 10 Global Onychomycosis Market by Region, 2018 - 2028, USD Million
FIG 11 Swot analysis: Abbott laboratories

Purchase Full Report of
Onychomycosis Market

Buy Now

Avail up to 60% discount on subscription plans on

SUBSCRIPTION MODEL